At TerThera b.v. we aim to make Terbium-161 globally available to solve the (future) shortage of radionuclides in support of cancer healthcare and providing a highly sustainable and uninterrupted supply chain.
In this extend, enabling out-patient healthcare to provide for a significant higher number of patients treated on polyclinical (daily) basis to mitigate the growing demand in cancer healthcare using Terbium-161, a superior radionuclide to the current market standard.
Contact us for your inquiries via support@terthera.com
Company Details
- Employees
- 6
- Founded
- -
- Address
- Minervum 7070, Breda,4817 Zk,netherlands
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.terthera.com
- Keywords
- TerThera..
- HQ
- Breda
Terthera B.v. Questions
Terthera B.V.'s website is http://www.terthera.com
Terthera B.V.'s LinkedIn profile is https://nl.linkedin.com/company/terthera
Terthera B.V. has
6 employees.
View email and phone details for 6
employees at Terthera B.V..
Terthera B.V.'s industry is
Pharmaceutical Manufacturing
Terthera B.V.'s categories are Pharmaceutical Manufacturing
Terthera B.V.'s founding year is 2021
